Haemonetics Corporation

Haemonetics Corporation Beats on EPS, Stock Up 1.3%

Haemonetics Corporation reported a better-than-expected EPS for Q3-2024, which contributed to a 1.3% increase in its stock price. However, there was no revenue data or guidance provided, leaving some uncertainty about future performance. Investors may be encouraged by the EPS beat but will likely seek more information in future reports.